YOLFTbeta
ORIENTBIO Inc.

ORIENTBIO Inc.

002630 · KO · Healthcare / Biotechnology

1,277.00KRW+4.00 (+0.31%)

Price History

Full chart

Market Stats

Previous Close1,273.00
Open1,328.00
Day Range1,270.00 – 1,328.00
52-Week Range1,490.00 – 3,264.00
Volume20.26K
Market Cap48.12B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.04
50-Day Avg1,874.52
200-Day Avg2,068.55

About

ORIENT BIO Inc. operates in the bio-industry in South Korea and internationally. It engages in the production, export, import, and life science-related research and development of laboratory animals; and offers various equipment for research environment. The company also provides infrastructural solution; health checking; generic testing; molecular biological generic testing; generic transformation; phenotyping; preconditioning; surgical treatment; transgenic services; eggs and avian research; support services for husbandry tasks; diagnostic and kits; claim management; serology regents; supply of biological materials used for new drug development process; and mouse, rat, and hamster antibody production testing services. In addition, it engages in automotive and automobile parts production and sales; preclinical and clinical trial agency business; manufacturing, import, and export pharmaceuticals, manufacturing, processing, wholesaling, and retailing of watches; and construction works. It has strategic partnerships with ELLEGARD in the Netherlands and CSIMC in China. It serves research institutions, pharmaceutical companies, and healthcare providers. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. ORIENT BIO Inc. was founded in 1959 and is headquartered in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Jae-Jin Chang
  • Employees0
  • Headquarters322, Galmachi-ro, Seongnam-si, South Korea, Korea
  • Websitehttps://www.orient.co.kr

Leadership

  • Mr. Jae-Jin ChangChairperson, President & CEO · b. 1961
  • Mr. Tae-Seok HanManaging Director of Sales · b. 1977

Financials

Income Statement

Currency: KRW2006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Revenue20.19B22.45B43.86B42.80B44.74B48.17B52.05B76.98B83.72B93.71B105.05B109.02B121.21B30.37B37.70B52.02B26.28B28.82B28.01B29.40B29.75B
Growth (%)-+11.21%+95.34%-2.40%+4.52%+7.68%+8.06%+47.89%+8.76%+11.93%+12.10%+3.78%+11.18%-74.94%+24.12%+37.99%-49.49%+9.68%-2.82%+4.97%+1.21%
Cost of Revenue19.57B13.62B27.23B27.75B29.80B35.51B36.19B57.12B67.46B77.56B89.32B100.65B106.28B27.36B30.50B32.79B17.26B18.99B18.42B22.20B24.57B
Gross Profit--------12.80B16.15B15.73B8.37B14.92B3.01B7.20B19.23B9.01B9.82B9.58B7.20B5.18B
Gross Margin--------15.28%17.23%14.97%7.68%12.31%9.91%19.10%36.96%34.30%34.09%34.22%24.48%17.42%
Operating Expense--------16.18B15.60B13.45B17.66B21.49B12.24B18.45B16.92B12.79B6.36B5.13B10.27B9.32B
Operating Income-1.16B2.63B2.16B--148.45M3.49B-3.38B548.06M2.28B-9.29B-6.56B-9.23B-11.25B2.31B-3.78B3.47B4.45B-3.08B-4.13B
Operating Margin-5.15%6.01%5.05%--0.29%4.54%-4.04%0.58%2.17%-8.52%-5.41%-30.40%-29.84%4.44%-14.39%12.02%15.91%-10.46%-13.89%
EBITDA-------------3.81B-1.66B-6.95B-10.06B997.25M-9.25B15.61B-11.02B-2.23B
EBITDA Margin-------------3.14%-5.48%-18.45%-19.34%3.80%-32.09%55.75%-37.49%-7.51%
Net Income-526.73M---4.07B-878.82M-9.55B-1.75B-3.01B-19.13B-13.87B-19.51B-10.88B-15.27B34.20B-12.42B12.87B-13.19B-4.57B
Net Income Margin-2.35%---8.44%-1.14%-11.41%-1.87%-2.86%-17.54%-11.44%-64.22%-28.86%-29.36%130.15%-43.11%45.96%-44.88%-15.35%
R&D-----1.41B599.80M2.49B1.62B551.16M576.23M1.16B2.00B655.28M1.41B2.65B2.59B1.80B1.95B1.00B732.58M
R&D as % of Total Revenue-----2.92%1.15%3.23%1.93%0.59%0.55%1.07%1.65%2.16%3.73%5.09%9.88%6.25%6.95%3.40%2.46%
Interest Expense00000000000003.44B439.25M559.69M432.88M252.28M56.90M220.27M128.38M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%11.33%1.17%1.08%1.65%0.88%0.20%0.75%0.43%

Balance Sheet

Currency: KRW2006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Assets68.17B72.88B82.72B98.18B104.31B84.86B123.55B136.24B139.63B148.76B175.64B172.63B190.03B84.09B72.11B71.52B104.95B81.05B96.99B84.78B81.62B
Total Liabilities23.96B28.02B44.93B40.58B42.55B19.38B63.03B73.95B77.78B81.42B84.35B74.68B110.11B21.44B20.14B22.97B21.76B9.66B11.89B12.94B13.07B
Total Equity44.21B44.86B35.20B54.83B54.25B58.09B52.18B54.77B55.01B53.72B76.86B70.30B52.72B64.79B51.96B48.54B83.19B71.39B85.10B71.85B68.54B
Cash10.02B679.41M2.66B2.52B7.66B5.60B2.17B1.95B1.13B1.25B8.44B19.01B24.44B9.17B2.35B10.94B29.99B5.93B6.11B6.53B5.83B
Total Debt-23.84B37.30B32.51B34.17B11.83B49.00B56.42B56.46B58.59B58.52B51.70B64.15B8.25B7.22B8.11B7.40B----
Net Debt-23.16B34.65B29.99B26.51B6.22B46.83B54.47B55.34B57.34B50.08B32.69B39.71B-921.09M4.87B-2.83B-22.60B----

Cash Flow

Currency: KRW2007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Operating Cash Flow1.52B--9.35B3.11B-5.09B2.17B1.60B912.43M-5.11B-1.97B-11.54B-3.90B8.74B2.35B1.16B3.76B752.29M2.60B
Investing Cash Flow----16.03B---12.64B-8.04B-19.25B-5.10B-26.52B-26.73B-347.26M-4.03B-----
Financing Cash Flow7.12B9.81B15.40B2.59B-12.33B6.59B9.64B6.56B25.53B20.78B33.92B23.00B-2.58B3.87B-----
Capital Expenditure12.30B2.96B6.83B1.59B2.97B789.63M18.94B10.43B5.11B14.46B5.28B2.99B16.08B742.94M256.16M2.21B485.64M925.25M4.79B2.05B
Free Cash Flow------------5.56B-29.97B-6.55B8.48B140.53M674.30M2.83B-4.04B546.36M
FCF to OCF-----------282.70%259.71%167.89%97.07%5.98%58.13%75.37%-536.56%21.04%

Earnings

Report DateFeb 14, 2007Jun 30, 2010Sep 30, 2010Dec 31, 2010Jun 30, 2011Sep 30, 2011Aug 14, 2012Nov 14, 2012Dec 31, 2012May 12, 2013Jun 30, 2013Oct 12, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Jun 30, 2022Sep 30, 2022Feb 13, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Jun 27, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate66.28------------------------------------------------------------
EPS Actual43.877.74-73.30716.570.000.006.884.6059.18-13.52-73.79-50.42-57.24-435.37-13.6522.98-51.26-93.27-82.49-52.2160.18-122.06-414.54-25.16-512.78-94.32-66.87-280.95-251.02-137.72-176.71-412.50102.09-35.20-251.23-35.15-106.00-15.01-322.43137.79-334.1690.76-7.4631.71-301.07293.13-107.1117.2678.15-21.937.2092.70-228.86-36.82-44.01-138.63-68.55-5.10-64.74-15.6881.75
Surprise-33.81%------------------------------------------------------------
TimingPre-market------Pre-market-Pre-market-Pre-market----------------------------------After-hours----Pre-market---------

Key Statistics & Ratios

Market Cap48.12B
Enterprise Value17.33B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.81
Price / Book0.75
Revenue (TTM)59.09B
Gross Profit (TTM)21.25B
EBITDA1.34B
Profit Margin-11.60%
Operating Margin5.89%
Return on Equity-12.42%
Return on Assets-2.20%
Shares Outstanding29.65M
Shares Float22.48M
Beta-0.04
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20001×
72.76Mar 30, 2000
19981×
36.38Mar 30, 1998
19971×
72.76Mar 29, 1997
19961×
72.76Mar 30, 1996

Stock Splits

  • Jun 9, 20261:2
  • Feb 21, 20200.4454:1
  • Jul 18, 20035:1